Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer
Overview of attention for article published in Journal of Clinical Oncology, December 2013
Altmetric Attention Score: 31
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (82nd percentile)
Mentioned by
- news
- 1 news outlet
- policy
- 1 policy source
- 18 X users
- patent
- 14 patents
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 134 Mendeley